Market Value1,209,215,773
Total Holdings58
File Date2024-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AGIO / Agios Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ATRA / Atara Biotherapeutics, Inc.
SLDB / Solid Biosciences Inc.
RLMD / Relmada Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
ALXO / ALX Oncology Holdings Inc.
ALPN / Alpine Immune Sciences, Inc.
JAZZ / Jazz Pharmaceuticals plc
LYRA / Lyra Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
TGTX / TG Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
LXEO / Lexeo Therapeutics, Inc.
NARI / Inari Medical, Inc.
EXAS / Exact Sciences Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BLUE / bluebird bio, Inc.
IKNA / Ikena Oncology, Inc.
MRK / Merck & Co., Inc.
CBAY / CymaBay Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc.
AVTE / Aerovate Therapeutics, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
NUVL / Nuvalent, Inc.
AFMD / Affimed N.V.
BIIB / Biogen Inc.
VRDN / Viridian Therapeutics, Inc.
INBX / Inhibrx Biosciences, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
PYXS / Pyxis Oncology, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
OVID / Ovid Therapeutics Inc.
RPHM / Reneo Pharmaceuticals, Inc.
FULC / Fulcrum Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
PCRX / Pacira BioSciences, Inc.
SWAV / Shockwave Medical, Inc.
PRME / Prime Medicine, Inc.
INCY / Incyte Corporation
BIO / Bio-Rad Laboratories, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
NBIX / Neurocrine Biosciences, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
PRAX / Praxis Precision Medicines, Inc.
SLNO / Soleno Therapeutics, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
PASG / Passage Bio, Inc.
ALLO / Allogene Therapeutics, Inc.
AFMD / Affimed N.V.
INSM / Insmed Incorporated
LQDA / Liquidia Corporation
QURE / uniQure N.V.
FATE / Fate Therapeutics, Inc.
GMED / Globus Medical, Inc.
RVMD / Revolution Medicines, Inc.
EW / Edwards Lifesciences Corporation
DNTH / Dianthus Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
APLT / Applied Therapeutics, Inc.
IMTX / Immatics N.V.
ANRO / Alto Neuroscience, Inc.
GERN / Geron Corporation
ACLX / Arcellx, Inc.
VYGR / Voyager Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
CYTK / Cytokinetics, Incorporated
SRPT / Sarepta Therapeutics, Inc.
LYEL / Lyell Immunopharma, Inc.
NVAX / Novavax, Inc.
ATXS / Astria Therapeutics, Inc.
CMRX / Chimerix, Inc.
VKTX / Viking Therapeutics, Inc.
MGNX / MacroGenics, Inc.